Tag Archives: Publication Strategy

FOUR (NOT) TO DO’S TO PREVENT PAPER WITHDRAWAL

The vote regarding the proposed Medical Device Regulation is once more postponed, so we will need some more patience before knowing where we are heading in Europe with the Medical Device Directive. One thing, however, speaks clearly from the proposal … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

PUBLISH OR PERISH

Although retractions may sometimes suggest otherwise, publication of clinical data is how to obtain the return on a clinical trial investment. The clinical trial investment is substantial as the process to collect clinical evidence from research sites is involved and … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , | 2 Comments

CAN YOU IMPROVE YOUR CLINICAL EVIDENCE BASE WITHOUT ADDITIONAL TRIALS?

Transparency and public accessibility to clinical studies greatly improved since 2005 when the ICMJE (International Committee of Medical Journal Editors) decided that no trials will be considered for publication unless they are included on a clinical trials registry. Publication Bias … Continue reading

Posted in Uncategorized | Tagged , , , , , , | 1 Comment